iiinova — where your digital self keeps evolving

Rob Winder @robwinder.bsky.social · 12/08/2026

Well said @dereklowe.bsky.social The Proposed Changes in Childhood Vaccination: A Strongly Felt Opinion | Science | AAAS www.science.org/content/blog...

science.org

The Proposed Changes in Childhood Vaccination: A Strongly Felt Opinion

021

Rob Winder @robwinder.bsky.social · 24/07/2026

Thanks. I can see that. It surprises me how much a company is prepared to "give away" so they can claim their IPO is "oversubscribed" and they get a big "Pop" on launch

010

Rob Winder @robwinder.bsky.social · 23/07/2026

Useful. Is there a reason you chose to do the comparison against the first day price rather than the list price?

100

Rob Winder @robwinder.bsky.social · 20/07/2026

I can think of several that didn't. Makes a significant difference.

010

Rob Winder @robwinder.bsky.social · 07/07/2026

He only plays on the "far right"

010

Rob Winder @robwinder.bsky.social · 15/06/2026

I'm not convinced a ban on under-16s using social media is the best answer to the problem. I wonder whether only allowing people with verified identity to post/like/share would have a bigger impact in reducing hateful conversations

000

Rob Winder @robwinder.bsky.social · 02/06/2026

They probably should have read that @biocentury.bsky.social editorial before going down this road. Clueless! Will do little to stop Chinese biotech innovation. Will negatively impact patients in the longer term.

010

Rob Winder @robwinder.bsky.social · 30/05/2026

Another strong editorial from @biocentury.bsky.social. @steveusdin.bsky.social on the Republican destruction of US science and calling for biopharma CEOs to stand in oppostion. Probably unlikely as they and their trade orgs were all in for the Republicans, despite the clear warning signs.

biocentury.com

Pharma CEO silence is complicity in the destruction of U.S. science

Office of Management and Budget Director Russell Vought has poured gas on the foundations of science. Pharma CEOs should demand that President Donald Trump...

010

Rob Winder @robwinder.bsky.social · 29/05/2026

Thoughtful editorial from @fishburnsimone.bsky.social in @biocentury.bsky.social on the disappointing US response to Chinese biotech innovation - the results of the Chinese government's industrial strategy to build successful industries. Hopefully, the UK does not follow the blinkered, US approach.

biocentury.com

Take your head out of the sand on China: a Perspective

The ability of U.S. biotech executives, policymakers and some investors to deny the rising innovation and inventiveness from China is astonishing. But no d...

020

Rob Winder @robwinder.bsky.social · 19/05/2026

I am proud to have done my BSc and PhD at the @uniofnottingham.bsky.social School of Chemistry. The University is unwisely planning to cut staff in Chemistry. Please sign the open letter to help save the department: nottinghamchemistry.github.io/Open_Letter/

nottinghamchemistry.github.io

Save Nottingham Chemistry

100

Rob Winder @robwinder.bsky.social · 13/03/2026

We are looking for a consultant to join our strategic communications life sciences and healthcare team. If you are interested in helping us advise some of the leading companies in the sector, please apply. fticonsult.referrals.selectminds.com/fticareers/j...

fticonsult.referrals.selectminds.com

Consultant | Life Sciences and Healthcare | Strategic Communications in United Kingdom, England, London

We are looking for an enthusiastic self-starter who wants to join a market leading team that provides strategic communications to innovative...

002

Rob Winder @robwinder.bsky.social · 17/02/2026

I am proud to have signed up to @ukbiobank.bsky.social and am delighted to see that FINALLY they are getting access to the data from GPs. Ridiculous that this has been stifled by bureaucracy for twenty years. www.thetimes.com/uk/healthcar...

thetimes.com

Decades of medical insight unlocked as UK Biobank gets GP records

A legal breakthrough allows years of health information from half a million Britons to be studied, offering unprecedented data on disease and ageing

020

Rob Winder @robwinder.bsky.social · 13/02/2026

Strong editorial from @steveusdin.bsky.social in @biocentury.bsky.social calling for the CEOs of pharma companies to demand Vinay Prasad be fired. Given that pharma and biotech leaders actively backed Trump, knowing his policies, I doubt any of them will. www.biocentury.com/article/658404

biocentury.com

Pharma CEOs should demand Prasad’s departure

It is past time for life sciences industry leaders to publicly demand Vinay Prasad’s firing.If FDA Commissioner Marty Makary is unwilling to part wi...

010

Rob Winder @robwinder.bsky.social · 08/01/2026

This commentary by @natashaloder.bsky.social on the media coverage of the BMJ article on weight gain after patients stop using GLP-1s is a must read for those who communicate scientific information.

open.substack.com

The moral panic about GLP-1 rebound

Scientists and journalists are piling on the misery about the weight regain after medication

064

Rob Winder @robwinder.bsky.social · 05/12/2025

I think the sports bit stays with Warners as a new company. I'm sure they'll find a way of charging even more for DiscoveryPlus

100

Rob Winder @robwinder.bsky.social · 05/12/2025

It was an easy choice to make. "No Pasarán"

020

Rob Winder @robwinder.bsky.social · 15/09/2025

During the last election, I think the industry spent so much time distracted by the IRA and its potential impact on drug pricing that it missed the threats to the FDA and to scientific research and the potential imposition of tarrifs.

100

Rob Winder @robwinder.bsky.social · 15/09/2025

This is not good for the sector or for the health of patients. While the issue in the UK is, yet another, government that really does not understand the connection between investment and uptake of medicines, I feel the issue in the US may be self-inflicted.

110

Rob Winder @robwinder.bsky.social · 10/09/2025

This is not good at all. If the UK government really wants to support the life sciences it needs to encourage investment here, not discourage it. There have been at least seven government strategies for life sciences this century, it is time a government actually put one into action.

120

Rob Winder @robwinder.bsky.social · 18/08/2025

And none of those in between are duds.

020

Rob Winder @robwinder.bsky.social · 22/07/2025

This is not a "UK problem". The global biopharma industry has been built on M&A. If a company can be acquired for £46bn, as was the case with Shire, then any company can. What is important is that investors in companies being acquired make a sufficient return to want to invest in biotech again.

020

Rob Winder @robwinder.bsky.social · 22/07/2025

However, one area that I think will be impossible is to "build bigger, better British biotechs and keep them here, rather than them being sold to multinationals".

110

Rob Winder @robwinder.bsky.social · 22/07/2025

Kate Bingham's thoughts on the UK government's life sciences strategy are worth reading. The uptake of innovative products is essential if the Office for Life Sciences really wants to be successful in surpassing its goals.

ft.com

The UK needs to pick up the pace on life sciences

Focusing relentlessly on low drug costs is the wrong approach

330

Rob Winder @robwinder.bsky.social · 18/07/2025

Make that 40. First max score on Pointed.

000

Rob Winder @robwinder.bsky.social · 17/07/2025

It's always nice to see good news when you wake up. Congrats to the #moversandshakers team. A debate is only the first step, genuine action needs to be taken to help people get access to neurologists to enable early diagnosis.

000

Rob Winder @robwinder.bsky.social · 16/07/2025

I'm not surprised that the trade associations are not particularly positive in their responses to this report. There have been several similar ones since the turn of the century and successive govenments have always promised a lot and delivered only a fraction. I hope it is different this time.

000

Rob Winder @robwinder.bsky.social · 16/07/2025

The overarching ambition of the Life Sciences Sector Plan is admirable. However, I feel it is lacking detail. Additionally, there is a need to couple developing an innovative industry with the uptake of innovative products in the NHS. That appears to be missing.

gov.uk

Life Sciences Sector Plan

The Life Sciences Sector Plan sets out a vision and an action plan to drive growth, innovation, and better health outcomes.

100

Rob Winder @robwinder.bsky.social · 14/07/2025

On the AI theme, @parmy.bsky.social's "Supremacy"

010

Rob Winder @robwinder.bsky.social · 01/07/2025

I would agree on the prose. However, I think the recent iterations of some of the GPT systems have significantly improved prose compared with the output a few months ago, which will make recruitment for roles that require writing more difficult.

000

Rob Winder @robwinder.bsky.social · 30/06/2025

How do you separate the genuine writers from the AI-generated submissions? We found that significant numbers of our applicants last year used AI to generate work and in some cases CVs, and when candidates got to an assessment centre the quality of writing was much lower than seen in recent years

101

Rob Winder @robwinder.bsky.social · 12/05/2025

Need to be careful when comparing prices from one country to another. Industry talks about list prices (what they'd like to be paid) vs negotiated prices. I recall the US list price of some of the HCV drugs was 3x the negotiated price in EU, which in turn was higher than average price paid in US.

120

Rob Winder @robwinder.bsky.social · 11/04/2025

This was my favourite science road graffiti. From the 2020 Il Lombardia.

120

Rob Winder @robwinder.bsky.social · 09/04/2025

That is a sweet version of what maybe my favourite song of theirs.

000

Rob Winder @robwinder.bsky.social · 09/04/2025

Hitting the nail on the head...

000

Rob Winder @robwinder.bsky.social · 04/04/2025

We also noticed that the standard of writing in our assessment centre exercises left a lot to be desired.

000

Rob Winder @robwinder.bsky.social · 04/04/2025

This thread reflects my experience with our early talent recruitment this year. Many candidates using the same AI-generated phrases in their applications, and we saw some reading AI-drafted responses in real time in online interviews. AI is making recruitment much more challenging.

130

Rob Winder @robwinder.bsky.social · 01/04/2025

Lisa is correct here. Won't be holding my breath waiting for them to speak up though.

000

Rob Winder @robwinder.bsky.social · 14/03/2025

"Bluesky - AlphaMotorHomes - DeCeuster - Corendon" 😉

010

Rob Winder @robwinder.bsky.social · 20/02/2025

Pharma CEOS Speaking Up, Damn It | Science | AAAS www.science.org/content/blog...

science.org

Pharma CEOS Speaking Up, Damn It

000